TARGET
saveHER2
HER2/neu receptor; breast and gastric cancer target.
also known as: erbb2, her-2, neu
🐶 often sniffed alongside
top 8- tagOncology48 co-mentions · 8 sources
- tagBreast Cancer47 co-mentions · 8 sources
- tagAdCom19 co-mentions · 16 sources
- tag510(k) Clearance10 co-mentions · 10 sources
- tagPMA Approval8 co-mentions · 5 sources
- tagMonoclonal Antibody6 co-mentions · 3 sources
- drugpertuzumab + trastuzumab2 co-mentions · 1 sources
- drugpertuzumab2 co-mentions · 1 sources
drugs
0
catalysts
0
news
826
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buybiospace · 7h ago
- Roche breast cancer pill cleared by FDAbiopharma dive · 1d ago
- #CTAD26: Cognito plans FDA submission of light and sound therapy for Alzheimer’sendpoints · 1d ago
- Lilly signs $5.9B deal with Stipple to unlock oncology targetsfiercebiotech · 1d ago
- STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Rochestat · 1d ago
- Neurosterix pulls in $105M for schizophrenia drug, taps Cobenfy vetsendpoints · 6d ago
- VectorY bags $83.5M for antibody gene therapies in neurodegenerative diseasesendpoints · 7d ago
- BioNTech pays $205M for FDA voucher to speed up ‘late-stage oncology pipeline’fiercebiotech · 7d ago
Data sources
last refreshed 8h ago
Found something off?
comments(0)
5-min edit window · permanent after that